The global Ultrasonic Tissue Ablation System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Ultrasonic ablation is a noninvasive treatment for the removal of diseased tissue by the employment of sound waves to reduce chronic low-back and neck pain caused due to degeneration of joints.
The mechanism is similar to using a magnifying glass to focus sunlight. Focused ultrasound uses an acoustic lens to concentrate multiple intersecting beams of ultrasound on a target. Each individual beam passes through tissue with little effect but at the focal point where the beams converge, the energy can have useful thermal or mechanical effects. HIFU is typically performed with real-time imaging via ultrasound or MRI to enable treatment targeting and monitoring (including thermal tracking with MRI).
In the Chinese market, the main manufacturers are Chongqing Haifu, Haiying, Puluo Medical, Insightec Ltd and Shanghai A&S, etc.
The global Ultrasonic Tissue Ablation System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Âé¶¹Ô´´ Segmentation
By Company:
Chongqing Haifu
Haiying
Puluo Medical
InSightec Ltd
Shanghai A&S
By Type: (Dominant Segment vs High-Margin Innovation)
HIFU
MRgFUS
By Application: (Core Demand Driver vs Emerging Opportunity)
Uterine Fibroids
Other Cancers
By Region
Macro-Regional Analysis: Âé¶¹Ô´´ Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Âé¶¹Ô´´ Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Chongqing Haifu in Europe)
- Emerging Product Trends: HIFU adoption vs. MRgFUS premiumization
- Demand-Side Dynamics: Uterine Fibroids growth in China vs. Other Cancers potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Âé¶¹Ô´´s:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Ultrasonic Tissue Ablation System market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., MRgFUS in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Other Cancers in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Âé¶¹Ô´´ dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Ultrasonic Tissue Ablation System value chain, addressing:
- Âé¶¹Ô´´ entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Ultrasonic Tissue Ablation System Product Scope
1.2 Ultrasonic Tissue Ablation System by Type
1.2.1 Global Ultrasonic Tissue Ablation System Sales by Type (2020 & 2024 & 2031)
1.2.2 HIFU
1.2.3 MRgFUS
1.3 Ultrasonic Tissue Ablation System by Application
1.3.1 Global Ultrasonic Tissue Ablation System Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Uterine Fibroids
1.3.3 Other Cancers
1.4 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Estimates and Forecasts (2020-2031)
1.4.1 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Size in Value Growth Rate (2020-2031)
1.4.2 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Size in Volume Growth Rate (2020-2031)
1.4.3 Global Ultrasonic Tissue Ablation System Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Âé¶¹Ô´´ Size and Prospective by Region
2.1 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
2.2 Global Ultrasonic Tissue Ablation System Retrospective Âé¶¹Ô´´ Scenario by Region (2020-2025)
2.2.1 Global Ultrasonic Tissue Ablation System Sales Âé¶¹Ô´´ Share by Region (2020-2025)
2.2.2 Global Ultrasonic Tissue Ablation System Revenue Âé¶¹Ô´´ Share by Region (2020-2025)
2.3 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Ultrasonic Tissue Ablation System Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Ultrasonic Tissue Ablation System Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Âé¶¹Ô´´ Analysis
2.4.1 North America Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Size and Prospective (2020-2031)
2.4.2 Europe Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Size and Prospective (2020-2031)
2.4.3 China Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Size and Prospective (2020-2031)
2.4.4 Japan Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Size and Prospective (2020-2031)
3 Global Âé¶¹Ô´´ Size by Type
3.1 Global Ultrasonic Tissue Ablation System Historic Âé¶¹Ô´´ Review by Type (2020-2025)
3.1.1 Global Ultrasonic Tissue Ablation System Sales by Type (2020-2025)
3.1.2 Global Ultrasonic Tissue Ablation System Revenue by Type (2020-2025)
3.1.3 Global Ultrasonic Tissue Ablation System Price by Type (2020-2025)
3.2 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Ultrasonic Tissue Ablation System Sales Forecast by Type (2026-2031)
3.2.2 Global Ultrasonic Tissue Ablation System Revenue Forecast by Type (2026-2031)
3.2.3 Global Ultrasonic Tissue Ablation System Price Forecast by Type (2026-2031)
3.3 Different Types Ultrasonic Tissue Ablation System Representative Players
4 Global Âé¶¹Ô´´ Size by Application
4.1 Global Ultrasonic Tissue Ablation System Historic Âé¶¹Ô´´ Review by Application (2020-2025)
4.1.1 Global Ultrasonic Tissue Ablation System Sales by Application (2020-2025)
4.1.2 Global Ultrasonic Tissue Ablation System Revenue by Application (2020-2025)
4.1.3 Global Ultrasonic Tissue Ablation System Price by Application (2020-2025)
4.2 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Ultrasonic Tissue Ablation System Sales Forecast by Application (2026-2031)
4.2.2 Global Ultrasonic Tissue Ablation System Revenue Forecast by Application (2026-2031)
4.2.3 Global Ultrasonic Tissue Ablation System Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Ultrasonic Tissue Ablation System Application
5 Competition Landscape by Players
5.1 Global Ultrasonic Tissue Ablation System Sales by Players (2020-2025)
5.2 Global Top Ultrasonic Tissue Ablation System Players by Revenue (2020-2025)
5.3 Global Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ultrasonic Tissue Ablation System as of 2024)
5.4 Global Ultrasonic Tissue Ablation System Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Ultrasonic Tissue Ablation System, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Ultrasonic Tissue Ablation System, Product Type & Application
5.7 Global Key Manufacturers of Ultrasonic Tissue Ablation System, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.1.1 North America Ultrasonic Tissue Ablation System Sales by Company
6.1.1.1 North America Ultrasonic Tissue Ablation System Sales by Company (2020-2025)
6.1.1.2 North America Ultrasonic Tissue Ablation System Revenue by Company (2020-2025)
6.1.2 North America Ultrasonic Tissue Ablation System Sales Breakdown by Type (2020-2025)
6.1.3 North America Ultrasonic Tissue Ablation System Sales Breakdown by Application (2020-2025)
6.1.4 North America Ultrasonic Tissue Ablation System Major Customer
6.1.5 North America Âé¶¹Ô´´ Trend and Opportunities
6.2 Europe Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.2.1 Europe Ultrasonic Tissue Ablation System Sales by Company
6.2.1.1 Europe Ultrasonic Tissue Ablation System Sales by Company (2020-2025)
6.2.1.2 Europe Ultrasonic Tissue Ablation System Revenue by Company (2020-2025)
6.2.2 Europe Ultrasonic Tissue Ablation System Sales Breakdown by Type (2020-2025)
6.2.3 Europe Ultrasonic Tissue Ablation System Sales Breakdown by Application (2020-2025)
6.2.4 Europe Ultrasonic Tissue Ablation System Major Customer
6.2.5 Europe Âé¶¹Ô´´ Trend and Opportunities
6.3 China Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.3.1 China Ultrasonic Tissue Ablation System Sales by Company
6.3.1.1 China Ultrasonic Tissue Ablation System Sales by Company (2020-2025)
6.3.1.2 China Ultrasonic Tissue Ablation System Revenue by Company (2020-2025)
6.3.2 China Ultrasonic Tissue Ablation System Sales Breakdown by Type (2020-2025)
6.3.3 China Ultrasonic Tissue Ablation System Sales Breakdown by Application (2020-2025)
6.3.4 China Ultrasonic Tissue Ablation System Major Customer
6.3.5 China Âé¶¹Ô´´ Trend and Opportunities
6.4 Japan Âé¶¹Ô´´: Players, Segments, Downstream and Major Customers
6.4.1 Japan Ultrasonic Tissue Ablation System Sales by Company
6.4.1.1 Japan Ultrasonic Tissue Ablation System Sales by Company (2020-2025)
6.4.1.2 Japan Ultrasonic Tissue Ablation System Revenue by Company (2020-2025)
6.4.2 Japan Ultrasonic Tissue Ablation System Sales Breakdown by Type (2020-2025)
6.4.3 Japan Ultrasonic Tissue Ablation System Sales Breakdown by Application (2020-2025)
6.4.4 Japan Ultrasonic Tissue Ablation System Major Customer
6.4.5 Japan Âé¶¹Ô´´ Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Chongqing Haifu
7.1.1 Chongqing Haifu Company Information
7.1.2 Chongqing Haifu Business Overview
7.1.3 Chongqing Haifu Ultrasonic Tissue Ablation System Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Chongqing Haifu Ultrasonic Tissue Ablation System Products Offered
7.1.5 Chongqing Haifu Recent Development
7.2 Haiying
7.2.1 Haiying Company Information
7.2.2 Haiying Business Overview
7.2.3 Haiying Ultrasonic Tissue Ablation System Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Haiying Ultrasonic Tissue Ablation System Products Offered
7.2.5 Haiying Recent Development
7.3 Puluo Medical
7.3.1 Puluo Medical Company Information
7.3.2 Puluo Medical Business Overview
7.3.3 Puluo Medical Ultrasonic Tissue Ablation System Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Puluo Medical Ultrasonic Tissue Ablation System Products Offered
7.3.5 Puluo Medical Recent Development
7.4 InSightec Ltd
7.4.1 InSightec Ltd Company Information
7.4.2 InSightec Ltd Business Overview
7.4.3 InSightec Ltd Ultrasonic Tissue Ablation System Sales, Revenue and Gross Margin (2020-2025)
7.4.4 InSightec Ltd Ultrasonic Tissue Ablation System Products Offered
7.4.5 InSightec Ltd Recent Development
7.5 Shanghai A&S
7.5.1 Shanghai A&S Company Information
7.5.2 Shanghai A&S Business Overview
7.5.3 Shanghai A&S Ultrasonic Tissue Ablation System Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Shanghai A&S Ultrasonic Tissue Ablation System Products Offered
7.5.5 Shanghai A&S Recent Development
8 Ultrasonic Tissue Ablation System Manufacturing Cost Analysis
8.1 Ultrasonic Tissue Ablation System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Ultrasonic Tissue Ablation System
8.4 Ultrasonic Tissue Ablation System Industrial Chain Analysis
9 Âé¶¹Ô´´ing Channel, Distributors and Customers
9.1 Âé¶¹Ô´´ing Channel
9.2 Ultrasonic Tissue Ablation System Distributors List
9.3 Ultrasonic Tissue Ablation System Customers
10 Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Dynamics
10.1 Ultrasonic Tissue Ablation System Industry Trends
10.2 Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Drivers
10.3 Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Challenges
10.4 Ultrasonic Tissue Ablation System Âé¶¹Ô´´ Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Âé¶¹Ô´´ Size Estimation
12.1.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Chongqing Haifu
Haiying
Puluo Medical
InSightec Ltd
Shanghai A&S
Ìý
Ìý
*If Applicable.